Gutron (Midodrine Hydrochloride)

Gutron is indicated for the management of conditions characterized by low blood pressure when changing posture.

• Orthostatic hypotension (postural hypotension) where blood pressure falls upon standing.
• Symptomatic hypotension not related to posture, causing dizziness or fainting.
• Situations requiring short‑term blood pressure support under medical supervision.
• Adjunct therapy in chronic autonomic failure patients who experience recurrent dizziness.
• Off‑label consideration for severe vasovagal syncope, only when directed by a physician.

The safety profile of Gutron includes both frequently reported and less common adverse reactions, which are generally dose‑related and may resolve after dose adjustment.

Common

• Headache, usually mild, may improve with continued therapy or dose reduction.
• Piloerection (goosebumps), a characteristic skin reaction observed in some patients.
• Scalp tingling or pruritus, often transient and not severe.
• Nausea or abdominal discomfort, typically mild and may lessen over time.

Serious

• Supine hypertension, an increase in blood pressure while lying down that may require monitoring.
• Hypertensive crisis, a rapid and severe rise in blood pressure that can be dangerous if untreated.
• Cardiac arrhythmias, irregular heart rhythms that may need medical evaluation.

When prescribing Gutron, clinicians should consider several precautions to minimize risks and ensure appropriate use.

• Assess baseline supine and standing blood pressure before initiating therapy.
• Monitor blood pressure regularly, especially after dose changes or when the patient is lying down.
• Use caution in patients with cardiovascular disease, such as ischemic heart disease or heart failure.
• Avoid use in patients with severe renal impairment without dose adjustment.
• Counsel patients to remain upright for at least three hours after each dose to reduce supine hypertension.
• Evaluate pregnancy and lactation status, as safety data are limited.

Gutron can interact with other medications that affect blood pressure or adrenergic pathways; reviewing a patient’s medication list is essential.

Avoid

• Monoamine oxidase inhibitors (MAOIs) and other sympathomimetic agents, which may cause excessive hypertension.
• Direct vasoconstrictors such as ergot alkaloids, which can amplify blood pressure elevation.

Use with caution

• Diuretics, which may enhance the hypotensive effect when standing.
• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers), which could increase the risk of supine hypertension.
• Central nervous system depressants, as dizziness may be additive.
• Drugs affecting renal excretion, such as NSAIDs, which could alter midodrine clearance.